1161 Synthetic CD206 targeted constructs carrying pacletaxel or novel bisphosphonate payloads alter macrophages towards pro-inflammatory phenotypes; the paclitaxel construct improves the efficacy of anti-CTLA4 in CT26 tumors
Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.1161
Published Online: 2022-11-07
Published Print: 2022-11
Update policy: https://doi.org/10.1136/crossmarkpolicy
Ralph, David
Arnold, Jeffrey
Rosol, Michael
